rs104894760

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong

The NM_000054.7(AVPR2):​c.310C>T​(p.Arg104Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000183 in 1,092,691 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R104H) has been classified as Benign.

Frequency

Genomes: not found (cov: 25)
Exomes 𝑓: 0.0000018 ( 0 hom. 0 hem. )

Consequence

AVPR2
NM_000054.7 missense

Scores

12
3
2

Clinical Significance

Likely pathogenic criteria provided, multiple submitters, no conflicts P:5O:1

Conservation

PhyloP100: -0.789

Publications

20 publications found
Variant links:
Genes affected
AVPR2 (HGNC:897): (arginine vasopressin receptor 2) This gene encodes the vasopressin receptor, type 2, also known as the V2 receptor, which belongs to the seven-transmembrane-domain G protein-coupled receptor (GPCR) superfamily, and couples to Gs thus stimulating adenylate cyclase. The subfamily that includes the V2 receptor, the V1a and V1b vasopressin receptors, the oxytocin receptor, and isotocin and mesotocin receptors in non-mammals, is well conserved, though several members signal via other G proteins. All bind similar cyclic nonapeptide hormones. The V2 receptor is expressed in the kidney tubule, predominantly in the distal convoluted tubule and collecting ducts, where its primary property is to respond to the pituitary hormone arginine vasopressin (AVP) by stimulating mechanisms that concentrate the urine and maintain water homeostasis in the organism. When the function of this gene is lost, the disease Nephrogenic Diabetes Insipidus (NDI) results. The V2 receptor is also expressed outside the kidney although its tissue localization is uncertain. When these 'extrarenal receptors' are stimulated by infusion of a V2 selective agonist (dDAVP), a variety of clotting factors are released into the bloodstream. The physiologic importance of this property is not known - its absence does not appear to be detrimental in NDI patients. The gene expression has also been described in fetal lung tissue and lung cancer associated with alternative splicing. [provided by RefSeq, Jul 2008]
AVPR2 Gene-Disease associations (from GenCC):
  • diabetes insipidus, nephrogenic, X-linked
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • nephrogenic syndrome of inappropriate antidiuresis
    Inheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • nephrogenic diabetes insipidus
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 4 uncertain in NM_000054.7
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.958
PP5
Variant X-153905816-C-T is Pathogenic according to our data. Variant chrX-153905816-C-T is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 10853.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AVPR2NM_000054.7 linkc.310C>T p.Arg104Cys missense_variant Exon 3 of 4 ENST00000646375.2 NP_000045.1 P30518-1
AVPR2NM_001146151.3 linkc.310C>T p.Arg104Cys missense_variant Exon 3 of 3 NP_001139623.1 P30518-2
AVPR2NR_027419.2 linkn.466-203C>T intron_variant Intron 2 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AVPR2ENST00000646375.2 linkc.310C>T p.Arg104Cys missense_variant Exon 3 of 4 NM_000054.7 ENSP00000496396.1 P30518-1
ENSG00000284987ENST00000646191.1 linkn.96+3254G>A intron_variant Intron 1 of 4 ENSP00000493873.1 A0A2R8Y4P6

Frequencies

GnomAD3 genomes
Cov.:
25
GnomAD4 exome
AF:
0.00000183
AC:
2
AN:
1092691
Hom.:
0
Cov.:
36
AF XY:
0.00
AC XY:
0
AN XY:
361287
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26400
American (AMR)
AF:
0.00
AC:
0
AN:
35204
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30203
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54148
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35049
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4135
European-Non Finnish (NFE)
AF:
0.00000238
AC:
2
AN:
842102
Other (OTH)
AF:
0.00
AC:
0
AN:
46064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
25
Alfa
AF:
0.0000409
Hom.:
0

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:5Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:3
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 104 of the AVPR2 protein (p.Arg104Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with nephrogenic diabetes insipidus (PMID: 11232028, 14709855, 34101133). ClinVar contains an entry for this variant (Variation ID: 10853). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt AVPR2 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects AVPR2 function (PMID: 11232028, 19812297). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -

Diabetes insipidus, nephrogenic, X-linked Pathogenic:1
Jan 01, 2001
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Diabetes insipidus, nephrogenic, X-linked;C1845202:Nephrogenic syndrome of inappropriate antidiuresis Pathogenic:1
Jun 30, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nephrogenic diabetes insipidus Other:1
Oct 02, 2015
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:not provided
Review Status:no classification provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.42
BayesDel_addAF
Pathogenic
0.39
D
BayesDel_noAF
Pathogenic
0.32
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.82
D;D;.;D;.
FATHMM_MKL
Benign
0.29
N
LIST_S2
Pathogenic
0.99
.;.;D;D;D
M_CAP
Pathogenic
0.57
D
MetaRNN
Pathogenic
0.96
D;D;D;D;D
MetaSVM
Uncertain
0.48
D
MutationAssessor
Pathogenic
3.3
M;M;.;M;M
PhyloP100
-0.79
PrimateAI
Uncertain
0.76
T
PROVEAN
Pathogenic
-7.2
.;D;D;D;D
REVEL
Pathogenic
0.71
Sift
Pathogenic
0.0
.;D;D;D;D
Sift4G
Pathogenic
0.0
.;D;D;D;D
Polyphen
1.0
D;D;.;D;D
Vest4
0.76, 0.75, 0.63
MutPred
0.89
Loss of methylation at R104 (P = 0.035);Loss of methylation at R104 (P = 0.035);Loss of methylation at R104 (P = 0.035);Loss of methylation at R104 (P = 0.035);Loss of methylation at R104 (P = 0.035);
MVP
1.0
MPC
1.7
ClinPred
1.0
D
GERP RS
3.0
Varity_R
0.94
gMVP
0.83
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs104894760; hg19: chrX-153171270; COSMIC: COSV61686984; COSMIC: COSV61686984; API